Identification of a potent combination of key plasmodium falciparum merozoite antigens that elicit strain-transcending parasite-neutralizing antibodies

Infection and Immunity

Volumn 81, Issue 2, 2013, Pages 441-451

  Pandey, Alok K ^a   Reddy, K Sony ^a   Sahar, Tajali ^a   Gupta, Sonal ^a   Singh, Hina ^a   Reddy, E Jyotheeswara ^a   Asad, Mohd ^a   Siddiqui, Faiza A ^a   Gupta, Pankaj ^a   Singh, Bijender ^a,b   More, Kunal R ^a   Mohmmed, Asif ^a   Chitnis, Chetan E ^a   Chauhan, Virander S ^a   Gaur, Deepak ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b MAHARSHI DAYANAND UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; ASPARAGINE; IMMUNOGLOBULIN G; LIGAND; MALARIA VACCINE; NEUTRALIZING ANTIBODY; PARASITE ANTIGEN; SIALIC ACID; THROMBOSPONDIN;

ANIMAL MODEL; ANTIBODY RESPONSE; ANTIMICROBIAL ACTIVITY; ARTICLE; CELL ADHESION; CELL INVASION; CELL ORGANELLE; CONCENTRATION RESPONSE; ERYTHROCYTE; IMMUNOGENICITY; IN VITRO STUDY; MEROZOITE; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; RETICULOCYTE; SURFACE PROPERTY; VACCINATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ERYTHROCYTES; HOST-PARASITE INTERACTIONS; LIGANDS; MALARIA VACCINES; MALARIA, FALCIPARUM; MEROZOITES; MICE; MICE, INBRED BALB C; PLASMODIUM FALCIPARUM; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS;

EID: 84873026597     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01107-12     Document Type: Article

References (49)

1. Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD. 2012. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379:413-431.
2. Crompton PD, Pierce SK, Miller LH. 2010. Advances and challenges in malaria vaccine development. J. Clin. Invest. 120:4168-4178.
3. Ogutu BR, Apollo OJ, McKinney D, Okoth W, Siangla J, Dubovsky F, Tucker K, Waitumbi JN, Diggs C, Watts J, Malkin E, Leach A, Soisson LA, Milman JB, Otieno L, Holland CA, Polhemus M, Remich SA, Ockenhouse CF, Cohen J, Ballou WR, Martin SK, Angov E, Stewart VA, Lyon JA, Heppner DG, Withers MR. 2009. Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya. PLoS One 4:e4708. doi:10.1371 /journal.pone.0004708.
4. Spring MD, Cummings JF, Ockenhouse CF, Dutta S, Reidler R, Angov E, Bergmann-Leitner E, Stewart VA, Bittner S, Juompan L, Kortepeter MG, Nielsen R, Krzych U, Tierney E, Ware LA, Dowler M, Hermsen CC, Sauerwein RW, DE Vlas SJ, Ofori-Anyinam O, Lanar DE, Williams JL, Kester KE, Tucker K, Shi M, Malkin E, Long C, Diggs CL, Soisson L, Dubois MC, Ballou WR, Cohen J, Heppner DG, Jr. 2009. Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. PLoS One 4:e5254. doi:10.1371/journal.pone.0005254.
5. Thera MA, Doumbo OK, Coulibaly D, Laurens MB, Ouattara A, Kone AK, Guindo AB, Traore K, Traore I, Kouriba B, Diallo DA, Diarra I, Daou M, Dolo A, Tolo Y, Sissoko MS, Niangaly A, Sissoko M, Takala- Harrison S, Lyke KE, Wu Y, Blackwelder WC, Godeaux O, Vekemans J, Dubois MC, Ballou WR, Cohen J, Thompson D, Dube T, Soisson L, Diggs CL, House B, Lanar DE, Dutta S, Heppner DG, Jr, Plowe CV. 2011. A field trial to assess a blood-stage malaria vaccine. N. Engl. J. Med. 365:1004-1013.
6. Crompton PD, Miura K, Traore B, Kayentao K, Ongoiba A, Weiss G, Doumbo S, Doumtabe D, Kone Y, Huang CY, Doumbo OK, Miller LH, Long CA, Pierce SK. 2010. In vitro growth-inhibitory activity and malaria risk in a cohort study in Mali. Infect. Immun. 78:737-745.
7. Rono J, Färnert A, Olsson D, Osier F, Rooth I, Persson KE. 2012. Plasmodium falciparum line-dependent association of in vitro growthinhibitory activity and risk of malaria. Infect. Immun. 80:1900-1908.
8. Gaur D, Chitnis CE. 2011. Molecular interactions and signaling mechanisms during erythrocyte invasion by malaria parasites. Curr. Opin. Microbiol. 14:422-428.
9. Gaur D, Mayer DC, Miller LH. 2004. Parasite ligand-host receptor interactions during invasion of erythrocytes by Plasmodium merozoites. Int. J. Parasitol. 34:1413-1429.
10. Cowman AF, Crabb BS. 2006. Invasion of red blood cells by malaria parasites. Cell 124:755-766.
11. Hayton K, Gaur D, Liu A, Henschen B, Singh S, Lambert L, Furuya T, Bouttenot R, Doll M, Nawaz F, Mu J, Jiang L, Miller LH, Wellems TE. 2008. Erythrocyte binding protein PfRH5 polymorphisms determine species- specific pathways of Plasmodium falciparum invasion. Cell Host Microbe 4:40-51.
12. Baum J, Chen L, Healer J, Lopaticki S, Boyle M, Triglia T, Ehlgen F, Ralph SA, Beeson JG, Cowman AF. 2009. Reticulocyte-binding protein homologue 5-an essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum. Int. J. Parasitol. 39:371-380.
13. Crosnier C, Bustamante LY, Bartholdson SJ, Bei AK, Theron M, Uchikawa M, Mboup S, Ndir O, Kwiatkowski DP, Duraisingh MT, Rayner JC, Wright GJ. 2011. Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum. Nature 480:534-537.
14. Douglas AD, Williams AR, Illingworth JJ, Kamuyu G, Biswas S, Goodman AL, Wyllie DH, Crosnier C, Miura K, Wright GJ, Long CA, Osier FH, Marsh K, Turner AV, Hill AV, Draper SJ. 2011. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nat. Commun. 2:601. doi:10.1038/ncomms1615.
15. Lopaticki S, Maier AG, Thompson J, Wilson DW, Tham WH, Triglia T, Gout A, Speed TP, Beeson JG, Healer J, Cowman AF. 2011. Reticulocyte and erythrocyte binding-like proteins function cooperatively in invasion of human erythrocytes by malaria parasites. Infect. Immun. 79:1107-1117.
16. Stubbs J, Simpson KM, Triglia T, Plouffe D, Tonkin CJ, Duraisingh MT, Maier AG, Winzeler EA, Cowman AF. 2005. Molecular mechanism for switching of P. falciparum invasion pathways into human erythrocytes. Science 309:1384-1387.
17. Gaur D, Furuya T, Mu J, Jiang LB, Su XZ, Miller LH. 2006. Upregulation of expression of the reticulocyte homology gene 4 in the Plasmodium falciparum clone Dd2 is associated with a switch in the erythrocyte invasion pathway. Mol. Biochem. Parasitol. 145:205-215.
18. White NJ. 1999. Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia 41:301-308.
19. Chen L, Lopaticki S, Riglar DT, Dekiwadia C, Uboldi AD, Tham WH, O'Neill MT, Richard D, Baum J, Ralph SA, Cowman AF. 2011. An EGF-like protein forms a complex with PfRh5 and is required for invasion of human erythrocytes by Plasmodium falciparum. PLoS Pathog. 7:e1002199. doi:10.1371/journal.ppat.1002199.
20. Arumugam TU, Takeo S, Yamasaki T, Thonkukiatkul A, Miura K, Otsuki H, Zhou H, Long CA, Sattabongkot J, Thompson J, Wilson DW, Beeson JG, Healer J, Crabb BS, Cowman AF, Torii M, Tsuboi T. 2011. Discovery of GAMA, a Plasmodium falciparum merozoite micronemal protein, as a novel blood-stage vaccine candidate antigen. Infect. Immun. 79:4523-4532.
21. Rayner JC, Vargas-Serrato E, Huber CS, Galinski MR, Barnwell JW. 2001. A Plasmodium falciparum homologue of Plasmodium vivax reticulocyte binding protein (PvRBP1) defines a trypsin-resistant erythrocyte invasion pathway. J. Exp. Med. 194:1571-1581.
22. Triglia T, Duraisingh MT, Good RT, Cowman AF. 2005. Reticulocytebinding protein homologue 1 is required for sialic acid-dependent invasion into human erythrocytes by Plasmodium falciparum. Mol. Microbiol. 55:162-174.
23. Duraisingh MT, Triglia T, Ralph SA, Rayner JC, Barnwell JW, McFadden GI, Cowman AF. 2003. Phenotypic variation of Plasmodium falciparum merozoite proteins directs receptor targeting for invasion of human erythrocytes. EMBO J. 22:1047-1057.
24. Sahar T, Reddy KS, Bharadwaj M, Pandey AK, Singh S, Chitnis CE, Gaur D. 2011. Plasmodium falciparum reticulocyte binding-like homologue protein 2 (PfRH2) is a key adhesive molecule involved in erythrocyte invasion. PLoS One 6:e17102. doi:10.1371/journal.pone.0017102.
25. Gunalan K, Gao X, Liew KJ, Preiser PR. 2011. Differences in erythrocyte receptor specificity of different parts of the Plasmodium falciparum reticulocyte binding protein homologue 2a. Infect. Immun. 79:3421-3430.
26. Kaneko O, Mu J, Tsuboi T, Su X, Torii M. 2002. Gene structure and expression of a Plasmodium falciparum 220-kDa protein homologous to the Plasmodium vivax reticulocyte binding proteins. Mol. Biochem. Parasitol. 121:275-278.
27. Gaur D, Singh S, Singh S, Jiang L, Diouf A, Miller LH. 2007. Recombinant Plasmodium falciparum reticulocyte homology protein 4 binds to erythrocytes and blocks invasion. Proc. Natl. Acad. Sci. U. S. A. 104: 17789-17794.
28. Tham WH, Wilson DW, Lopaticki S, Schmidt CQ, Tetteh-Quarcoo PB, Barlow PN, Richard D, Corbin JE, Beeson JG, Cowman AF. 2010. Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand. Proc. Natl. Acad. Sci. U. S. A. 107: 17327-17332.
29. Gao X, Yeo KP, Aw SS, Kuss C, Iyer JK, Genesan S, Rajamanonmani R, Lescar J, Bozdech Z, Preiser PR. 2008. Antibodies targeting the PfRH1 binding domain inhibit invasion of Plasmodium falciparum merozoites. PLoS Pathog. 4:e1000104. doi:10.1371/journal.ppat.1000104.
30. Taylor HM, Grainger M, Holder AA. 2002. Variation in the expression of a Plasmodium falciparum protein family implicated in erythrocyte invasion. Infect. Immun. 70:5779-5789.
31. Sim BK, Chitnis CE, Wasniowska K, Hadley TJ, Miller LH. 1994. Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science 264:1941-1944.
32. Wickramarachchi T, Devi YS, Mohmmed A, Chauhan VS. 2008. Identification and characterization of a novel Plasmodium falciparum merozoite apical protein involved in erythrocyte binding and invasion. PLoS One 3:e1732. doi:10.1371/journal.pone.0001732.
33. Thompson J, Cooke RE, Moore S, Anderson LF, Janse CJ, Waters AP. 2004. PTRAMP; a conserved Plasmodium thrombospondin-related apical merozoite protein. Mol. Biochem. Parasitol. 134:225-232.
34. Green JL, Hinds L, Grainger M, Knuepfer E, Holder AA. 2006. Plasmodium thrombospondin related apical merozoite protein (PTRAMP) is shed from the surface of merozoites by PfSUB2 upon invasion of erythrocytes. Mol. Biochem. Parasitol. 150:114-117.
35. Pandey KC, Singh S, Pattnaik P, Pillai CR, Pillai U, Lynn A, Jain SK, Chitnis CE. 2002. Bacterially expressed and refolded receptor binding domain of Plasmodium falciparum EBA-175 elicits invasion inhibitory antibodies. Mol. Biochem. Parasitol. 123:23-33.
36. Duraisingh MT, Maier AG, Triglia T, Cowman AF. 2003. Erythrocytebinding antigen 175 mediates invasion in Plasmodium falciparum utilizing sialic acid-dependent and -independent pathways. Proc. Natl. Acad. Sci. U. S. A. 100:4796-4801.
37. Jiang L, Gaur D, Mu J, Zhou H, Long CA, Miller LH. 2011. Evidence for EBA-175 as a component of a ligand blocking blood stage malaria vaccine. Proc. Natl. Acad. Sci. U. S. A. 108:7553-7558.
38. Mamillapalli A, Pattnaik P, Sharma M, Sharma SK, Tyagi PK, Joshi H, Chitnis CE. 2006. Sequence polymorphisms in the receptor-binding domain of Plasmodium falciparum EBA-175: implications for malaria vaccine development. Mol. Biochem. Parasitol. 146:120-123.
39. Singh S, Alam MM, Pal-Bhowmick I, Brzostowski JA, Chitnis CE. 2010. Distinct external signals trigger sequential release of apical organelles during erythrocyte invasion by malaria parasites. PLoS Pathog. 6:e1000746. doi:10.1371/journal.ppat.1000746.
40. Sim B, Toyoshima T, Haynes J, Aikawa M. 1992. Localization of the 175-kilodalton erythrocyte binding antigen in micronemes of Plasmodium falciparum merozoites. Mol. Biochem. Parasitol. 51:157-159.
41. Healer J, Crawford S, Ralph S, McFadden G, Cowman AF. 2002. Independent translocation of two micronemal proteins in developing Plasmodium falciparum merozoites. Infect. Immun. 70:5751-5758.
42. Walliker D, Quakyi IA, Wellems TE, McCutchan TF, Szarfman A, London WT, Corcoran LM, Burkot TR, Carter R. 1987. Genetic analysis of the human malaria parasite Plasmodium falciparum. Science 236:1661-1666.
43. Wellems TE, Oduola AMJ, Fenton B, Deasjardins R, Panton LJ, do Rosario VE. 1988. Chromosome size variation occurs in cloned Plasmodium falciparum on in vitro cultivation. Rev. Bras. Genet. 11:813-825.
44. Bhasin VK, Trager W. 1984. Gametocyte-forming and non-gametocyteforming clones of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 33: 534-537.
45. Miller LH, Haynes JD, McAuliffe FM, Shiroishi T, Durocher JR, McGinniss MH. 1977. Evidence for differences in erythrocyte surface receptors for the malarial parasites, Plasmodium falciparum and Plasmodium knowlesi. J. Exp. Med. 146:277-281.
46. Burkot TR, Williams JL, Schneider I. 1984. Infectivity to mosquitoes of Plasmodium falciparum clones grown in vitro from the same isolate. Trans. R. Soc. Trop. Med. Hyg. 78:339-341.
47. Trager W, Jensen JB. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
48. Stoop JW, Zegers BJ, Sander PC, Ballieux RE. 1969. Serum immunoglobulin levels in healthy children and adults. Clin. Exp. Immunol. 4:101-112.
49. Duan J, Mu J, Thera MA, Joy D, Kosakovsky Pond SL, Diemert D, Long C, Zhou H, Miura K, Ouattara A, Dolo A, Doumbo O, Su XZ, Miller L. 2008. Population structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1: implications for vaccine design. Proc. Natl. Acad. Sci. U. S. A. 105:7857-7862.